Follicular large-cell lymphoma treated with intensive chemotherapy: An analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma

Journal of Clinical Oncology

Volumn 15, Issue 4, 1997, Pages 1654-1663

  Wendum, Dominique ^a   Sebban, Catherine ^a   Gaulard, Philippe ^a   Coiffier, Bertrand ^a   Tilly, Hervé ^a   Cazals, Dominique ^a   Boehn, Andréas ^a   Casasnovas, René Olivier ^a   Bouabdallah, Redah ^a   Jaubert, Jérome ^a   Ferrant, Augustin ^a   Diebold, Jacques ^a   de Mascarel, Antoine ^a   Gisselbrecht, Christian ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BLEOMYCIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; BONE MARROW; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE CLASSIFICATION; DOSE RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 17644432642     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.4.1654     Document Type: Article

References (31)

1. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112-2135, 1982
2. Harris NL, Jaffe ES, Stein H, et al: A revised European-American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
3. Stansfeld AG, Diebold J, Noel H, et al: Updated Kiel classification for lymphomas. Lancet 1:292-293, 1988
4. Bartlett NL, Rizeq M, Dorfman RF, et al: Follicular large cell lymphoma: Intermediate or low-grade? J Clin Oncol 12:1349-1357, 1994
5. Longo DL: What's the deal with follicular lymphomas? J Clin Oncol 11:202-208, 1993
6. Haioun C, Lepage E, Gisselbrecht C, et al: Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma in first complete remission. A study of 464 patients. J Clin Oncol 12:2543-2551, 1994
7. Coiffier B, Gisselbrecht C, Herbrecht R, et al: A multicenter study of intensive chemotherapy in 737 patients with agressive malignant lymphoma. J Clin Oncol 7:1018-1026, 1989
8. Horning SJ, Weiss LM, Nevitt JB, et al: Clinical and pathologic features of folliculare large cell (nodular histiocytic lymphoma). Cancer 59:1470-1474, 1987
9. Cordell JL, Falini B, Erber WN, et al: Immunoenzymatic labeling of monoclonal antibodies using complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219-229, 1984
10. Hermine O, Haioun C, Lepage E, et al: Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Blood 87:265-272, 1996
11. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
12. Peto R, Pike ML, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 35:1-39, 1977
13. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
14. Metter GE, Nathwani BN, Burke JS, et al: Morphological subclassification of follicular lymphoma: Variability of diagnoses among hematopathologists, a collaborative study between the repository center and pathology panel for lymphoma clinical studies. J Clin Oncol 3:25-38, 1985
15. NCI Non-Hodgkin's Classification Project Writing Committee: Classification of non-Hodgkin's lymphomas: Reproducibility of major classification systems. Cancer 55:91-95, 1985
16. Kantarjian HM, McLaughlin P, Fuller LM, et al: Follicular large-cell lymphoma: Analysis and prognostic factors in 62 patients. J Clin Oncol 2:811-819, 1984
17. Mann RB, Berard CW: Criteria for the cytologic subclassification of follicular lymphomas: A proposed alternative method. Hematol Oncol 1:187-192, 1983
18. Nathwani BN, Metter GE, Miller TP, et al: What should be the morphologic criteria for the subdivision of follicular lymphomas? Blood 68:837-845, 1986
19. Anderson JR, Vose JM, Bierman PJ, et al: Clinical features and prognosis of follicular large-cell lymphoma: A report from the Nebraska Lymphoma Study Group. J Clin Oncol 11:218-224, 1993
20. Glick JH, McFadden E, Costello W, et al: Nodular histiocytic lymphoma: Factors influencing prognosis and implications for aggressive chemotherapy. Cancer 49:840-845, 1982
21. Osborne CK, Norton L, Young RC, et al: Nodular histiocytic lymphoma: An aggressive nodular lymphoma with potential for prolonged disease-free survival. Blood 56:98-103, 1980
22. Stewart ML, Felman IE, Nichols PW, et al: Large noncleaved follicular center cell lymphoma. Clinical features in 53 patients. Cancer 57:288-297, 1986
23. Kramer MHH, Hermans J, Parker J, et al: The clinical significance of bcl-2 and p53 protein expression in diffuse large B-cell lymphoma: A population based study. J Clin Oncol 14:2131-2138, 1996
24. Cleary ML, Sklar J: Nucleotide sequence of a t(14; 18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint- cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439-7443, 1985
25. Weiss LM, Warnke RA, Sklar J, et al: Molecular analysis of the t(14; 18) chromosomal translocation in malignant lymphomas. N Engl J Med 317:1185-1189, 1987
26. Pezzella F, Tse AGD, Cordell JL, et al: Expression of the bcl-2 oncogene protein is not specific for the 14; 18 chromosomal translocation. Am J Pathol 137:225-232, 1990
27. Gaulard P, d'Agay MF, Peuchmaur M, et al: Expression of the bcl-2 gene product in follicular lymphoma. Am J Pathol 140:1089-1095, 1992
28. Korsmeyer SJ: bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879-886, 1992
29. Barry MA, Behnke CA, Eastman A: Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins, and hyperthermia. Biochem Pharmacol 40:2353-2362, 1990
30. Miyashita T, Reed JC: bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151-157, 1993
31. Solal-Celigny P, Lepage E, Brousse N, et al: Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. N Engl J Med 329:1608-1614, 1993